共 50 条
- [31] HYPOCHOLESTEROLEMIC EFFECT OF PANTETHINE - AN OPEN STUDY VERSUS PROCETOFEN IN TYPE-IIA AND TYPE-IIB HYPERCHOLESTEROLEMIA [J]. MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1984, 4 (01): : 58 - 60
- [32] EFFECTS OF MEDIUM-TERM PROBUCOL TREATMENT ON PLASMA-LIPIDS AND LIPOPROTEINS - 16 CASES OF TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA [J]. NOUVELLE PRESSE MEDICALE, 1980, 9 (40): : 3014 - 3017
- [34] TYPE-IV HYPERLIPOPROTEINEMIA [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (23) : 941 - 941
- [35] INCREASED ERYTHROCYTIC AND THROMBOCYTIC MEMBRANOUS FLUIDITIES IN TYPE-IIB AND TYPE-IV HYPERLIPIDEMIAS [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1987, 80 (05): : 701 - 701
- [36] EFFECTS OF CETABEN ON LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLEMIA, TYPE-IIA AND TYPE-IIB PHENOTYPES [J]. CLINICAL RESEARCH, 1984, 32 (02): : A244 - A244
- [38] INFLUENCE OF TYPE-IIA, TYPE-IIB AND IV-HYPER-LIPOPROTEINEMIA ON PLATELET PROSTAGLANDIN SENSITIVITY, PLASMA THROMBOXANE-B2 AND PLATELET HALF-LIFE [J]. PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1986, 25 (01): : 39 - 47
- [39] EFFECT OF ETOFYLLINE CLOFIBRATE ON THE COMPOSITION OF LIPOPROTEINS IN HYPERLIPEMIA TYPE-IIB AND TYPE-IV [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1980, 30-2 (NB11): : 2063 - 2067
- [40] LATHOSTEROL LEVEL IN PLASMA IS ELEVATED IN TYPE-III HYPERLIPOPROTEINEMIA, BUT NOT IN NON-TYPE-III SUBJECTS WITH APOLIPOPROTEIN E2/2 PHENOTYPE, NOR IN TYPE-IIA OR TYPE-IIB HYPERLIPOPROTEINEMIA [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (03): : 231 - 235